Arm Holdings plc - American Depositary Shares (ARM)
125.28
+3.09 (2.53%)
NASDAQ · Last Trade: Feb 16th, 2:00 PM EST
Detailed Quote
| Previous Close | 122.19 |
|---|---|
| Open | 120.12 |
| Bid | 125.01 |
| Ask | 125.36 |
| Day's Range | 119.70 - 127.42 |
| 52 Week Range | 80.00 - 183.16 |
| Volume | 4,418,709 |
| Market Cap | - |
| PE Ratio (TTM) | 167.04 |
| EPS (TTM) | 0.8 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 8,446,439 |
Chart
About Arm Holdings plc - American Depositary Shares (ARM)
Arm Holdings plc is a leading technology company that specializes in semiconductor and software design, primarily focusing on microprocessor and system-on-chip (SoC) architectures. Its innovative designs are integral to a wide range of applications, from mobile devices to embedded systems and Internet of Things (IoT) products. Arm's technology enables low power consumption and efficient performance, making it a popular choice among manufacturers and developers in the electronics industry. The company collaborates closely with partners to drive the advancement of next-generation computing and connectivity solutions, playing a crucial role in shaping the future of digital devices and applications. Read More
News & Press Releases
Via MarketBeat · February 16, 2026
As of February 16, 2026, the American economic landscape has split into two starkly different realities, creating a "K-shaped" trajectory that financial experts warn could be the precursor to a significant market correction. This divergence—where high-income earners continue to see their wealth expand while middle- and lower-income households struggle
Via MarketMinute · February 16, 2026
As of February 16, 2026, UnitedHealth Group (NYSE: UNH) finds itself at a historic crossroads. For decades, the Minnesota-based behemoth has been the undisputed bellwether of the American healthcare system—a compounding machine that rarely missed a beat. However, early 2026 has brought unprecedented volatility to the healthcare giant. Following a catastrophic January that saw the [...]
Via Finterra · February 16, 2026
In the upper echelons of the American homebuilding industry, NVR, Inc. (NYSE: NVR) has long been regarded as the gold standard of capital efficiency. However, the market’s reaction in mid-February 2026 has left even seasoned analysts scratching their heads. On February 11, 2026, NVR’s board approved a fresh $750 million share repurchase authorization—a move that [...]
Via Finterra · February 16, 2026
Semiconductors are the foundation upon which technology is built, and this company is ringing the cash register.
Via The Motley Fool · February 16, 2026
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via StockStory · February 15, 2026
Most investors are overlooking a critical detail about the way this semiconductor company's business works.
Via The Motley Fool · February 15, 2026
Most investors aren't fans of the plan, but they'd dislike the outcome of the alternative even more.
Via The Motley Fool · February 14, 2026
America sold a lot of weapons in January. Lockheed Martin will make the most profit.
Via The Motley Fool · February 14, 2026
Humana Inc. (NYSE:HUM) shares experienced a sharp sell-off this week after the health insurance giant issued a surprisingly conservative financial outlook for 2026. The company warned investors that a massive $3.5 billion net headwind stemming from a decline in Medicare Advantage (MA) Star Ratings would severely compress margins,
Via MarketMinute · February 13, 2026
The semiconductor industry has entered 2026 in a state of "High-Stakes Paradox," where historic revenue peaks driven by a $650 billion artificial intelligence infrastructure buildout are being tempered by acute supply chain chokepoints and a widening divide between high-performance computing and the struggling automotive sector. As of February 13, 2026,
Via MarketMinute · February 13, 2026
The two e-commerce conglomerates have both struggled primarily because of their non-e-commerce businesses.
Via The Motley Fool · February 13, 2026
NIH stops rivaroxaban arm in CAPTIVA stroke trial after safety events and futility signal; study continues with other treatment groups.
Via Benzinga · February 11, 2026
Date: February 11, 2026 Introduction In the first few weeks of 2026, a singular healthcare name has dominated the screens of institutional traders and retail investors alike: DaVita Inc. (NYSE: DVA). Once viewed with skepticism in late 2023 as the "Ozempic era" threatened to upend chronic kidney disease (CKD) management, DaVita has staged a remarkable [...]
Via Finterra · February 11, 2026
As of February 11, 2026, the turnaround story of Lumen Technologies (NYSE: LUMN) has shifted from a speculative "distressed asset" play into a focused narrative on artificial intelligence (AI) infrastructure. Once a sprawling telecommunications giant struggling under a mountain of debt and legacy copper assets, Lumen has spent the last three years reinventing itself. Today, [...]
Via Finterra · February 11, 2026
As of February 11, 2026, Humana Inc. (NYSE: HUM) finds itself at a historic crossroads. Once the darling of the managed care sector, the Louisville-based insurer is currently navigating a "perfect storm" of regulatory tightening, rising medical utilization, and a catastrophic decline in quality bonus payments. Today’s research deep-dive follows a volatile morning on Wall [...]
Via Finterra · February 11, 2026
On February 11, 2026, Shopify Inc. (NYSE: SHOP; TSX: SHOP) silenced skeptics and reaffirmed its status as the global operating system for commerce. Following the release of its Q4 2025 earnings report this morning, the company’s stock surged over 12% in early trading, fueled by a "double beat" on revenue and earnings, optimistic 2026 guidance, [...]
Via Finterra · February 11, 2026
Date: February 11, 2026 Introduction Ford Motor Company (NYSE: F) finds itself at a critical crossroads today, following the release of its full-year 2025 earnings report. In a year defined by extreme volatility—ranging from massive supply chain disruptions to a fundamental pivot in its electric vehicle (EV) strategy—the Detroit giant has emerged with a narrative [...]
Via Finterra · February 11, 2026
As of February 11, 2026, the industrial landscape is witnessing a significant shift in the perceived value of heavy equipment manufacturing, and at the center of this movement is Wabtec Corporation (NYSE: WAB). Formally known as Westinghouse Air Brake Technologies Corporation, Wabtec has transformed from a traditional component manufacturer into a high-tech cornerstone of global [...]
Via Finterra · February 11, 2026
Today, February 11, 2026, marks a volatile chapter for Moderna, Inc. (NASDAQ: MRNA). The biotechnology pioneer, which became a household name during the COVID-19 pandemic, finds itself at a critical crossroads following a major regulatory setback that has sent shockwaves through the healthcare sector. As the company attempts to transition from a "one-hit wonder" pandemic [...]
Via Finterra · February 11, 2026
Memory shortages have the potential to crimp Arm's growth next year.
Via The Motley Fool · February 10, 2026
As of February 10, 2026, Ford Motor Company (NYSE: F) stands at a defining crossroads in its 123-year history. After a turbulent 2025 that saw the company navigate significant supply chain disruptions and a massive restructuring of its electric vehicle (EV) ambitions, Ford is currently the primary case study for "legacy" transition in the automotive [...]
Via Finterra · February 10, 2026
Today, February 10, 2026, Harley-Davidson, Inc. (NYSE: HOG) finds itself at a defining crossroads. Long the undisputed symbol of American heavy-metal rebellion, the "Motor Company" is currently navigating a painful but necessary structural reset. After a five-year strategic cycle known as the "Hardwire," which focused on high-margin heavyweight touring bikes, the company has entered 2026 [...]
Via Finterra · February 10, 2026
Date: February 10, 2026 Introduction As of February 10, 2026, The Coca-Cola Company (NYSE: KO) stands at a historic crossroads. For over a century, the Atlanta-based behemoth has served as the ultimate "defensive" play for global investors—a bastion of stability through recessions, world wars, and technological revolutions. Today, the company is navigating a profound transformation. [...]
Via Finterra · February 10, 2026